Colorectal cancer (CRC) remains one of the most prevalent cancer types globally, with significant mortality rates. Traditional oral administration of anticancer drugs poses substantial challenges affecting therapeutic efficiency. To address these issues, a group of researchers from Pusan National University led by Prof. Jin-Wook Yoo has developed a groundbreaking strategy involving self-protecting nanoparticles that enhance drug delivery specifically targeting colorectal cancer.

Challenges in Colorectal Cancer Treatment

The common strategy of administering anticancer drugs orally encounters several obstacles:

  • Lack of Target Specificity: Most drugs exhibit off-target side effects, which can lead to significant health complications.
  • Premature Drug Adsorption: Many drugs are easily adsorbed onto the microvilli structure of the small intestine, resulting in early loss of therapeutic agents.
  • Systemic Drug Absorption: This phenomenon diminishes the effective delivery of drugs specifically to the colorectum, reducing overall treatment efficacy.

Consequently, there is a pressing need for innovative strategies to ensure localized and precise drug delivery aimed at CRC.

Innovative Drug Delivery Strategy

The research team proposed a novel drug delivery scheme utilizing colorectal cancer cell-activated nanoconjugates (CTNCs) enclosed in a pH-sensitive alginate matrix. This approach aims to shield the drug from the gastric environment, ensuring its release only upon reaching the colorectal region.

According to Prof. Yoo, “The primary objective of our research is to synthesize a specific copolymer that allows for the formation of CTNCs. This is followed by their incorporation into an alginate matrix to achieve localized drug delivery, effectively avoiding systemic circulation.”

Drug Delivery Component Function Benefit
pH-sensitive Alginate Matrix Shield drugs from gastric acids Reduced premature drug loss
CTNCs Target specific CRC cells Enhanced therapeutic efficiency
HPI Copolymer Facilitates drug release upon cell interaction Localized anticancer effects

Mechanism of Action

The alginate matrix undergoes a sol-gel-sol transition when exposed to varying pH levels, effectively forming a protective gel in the acidic environment of the stomach and intestine. This action safeguards the CTNCs from premature loss until they reach the basic pH of the colorectum:

  • The sol-gel transition prevents unwanted interactions with the intestinal epithelium, facilitating drug passage.
  • Once in the colorectal environment, the matrix transitions back, releasing the CTNCs.
  • CTNCs interact specifically with the CD44 receptor on colorectal cancer cells, leading to targeted internalization.

This targeted approach allows for the intracellular release of the anticancer agent irinotecan due to cleavage by tumor cell-specific esterases, thus avoiding systemic effects.

Research Findings and Implications

The study demonstrates that this novel drug delivery mechanism significantly enhances the localized therapy of colorectal cancer. Prof. Yoo highlights that the strategy not only reduces off-target effects but also improves treatment precision and efficiency.

“These findings underscore the potential of reversible shielding and target cell-activated releasing strategies for the selective delivery of therapeutics to the colorectum.” – Prof. Jin-Wook Yoo

Potential for Broader Application

The proposed drug delivery strategy offers a framework that can be extended to other diseases affecting the colorectum, such as ulcerative colitis. With the capacity to improve both the specificity and effectiveness of treatments, this research holds promise for enhancing the quality of life for patients suffering from CRC and other similar conditions.

Conclusion

The development of self-protecting nanoparticles enclosed within a pH-sensitive alginate matrix represents a significant advancement in the localized treatment of colorectal cancer. By addressing the main challenges of drug delivery, this strategy opens avenues for better patient outcomes and efficiency in cancer therapy.

References

[1] Juho Lee et al. (2025). On-site sol-gel-sol transition of alginate enables reversible shielding/deshielding of tumor cell-activated nanoconjugates for precise local colorectal cancer therapy. Chemical Engineering Journal.

For further information, visit Phys.org.